MedTrace Logo

Walk It Off! the Influence of Physical Activity Level on the Recovery from Damaging Resistance Exercise

NCT06810271 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-02-05

No results posted yet for this study

Summary

After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.

Conditions

  • Exercise Induced Muscle Damage
  • Physical Activity
  • Inflammation
  • Exercise Recovery
  • Skeletal Muscle Damage
  • Young Adults
  • Delayed Onset Muscle Soreness (DOMS)

Interventions

BEHAVIORAL

Eccentric resistance exercise

150 maximal, unilateral eccentric contractions of the quadriceps muscles on a computerized dynamometer.

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-24
Primary Completion
2026-01-01
Completion
2026-05-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06810271 on ClinicalTrials.gov